Janet Kwee - Gynecology

Author Information

Dr. Janet Kwee is affiliated with the Department of Obstetrics and Gynecology at OLVG West, located in Amsterdam, the Netherlands. Her research primarily focuses on gynecology, with a significant emphasis on reproductive medicine and fertility treatments.

Research Contributions

Dr. Janet Kwee has made substantial contributions to the field of gynecology through her research on various topics, including the effectiveness of different fertility treatments, the diagnosis of tubal pathology, and innovative approaches to uterine cavity access. Notable studies include her work on Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy, and individualized FSH dosing in women undergoing IVF/ICSI. Her research has provided valuable insights into cost-effectiveness and clinical outcomes of various fertility treatments, benefiting both clinicians and patients.

Aliases

Dr. Janet Kwee is also known by the aliases J Kwee and J. Kwee.

Publication and Citation Metrics

Total Citations	2859
H-index	19
Number of Papers	28

Publications:

Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Long term results of a double-blind randomized controlled trial.

DOI: 10.1016/j.ejogrb.2020.06.035

Year: 2020

Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?

DOI: 10.1093/humrep/deaa052

Year: 2020

The capacity of transvaginal hydrolaparoscopy versus hysterosalpingography to diagnose tubal pathology in the work-up of subfertile women, a randomised clinical trial.

DOI: 10.1016/j.ejogrb.2019.02.035

Year: 2019

Cumulative live birth rates in low-prognosis women

DOI: 10.1093/humrep/dez051

Year: 2019

Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis

DOI: 10.1093/humrep/dey359

Year: 2019

A Novel Approach to Transmural Access to the Uterine Cavity in Cases of an Inaccessible Uterine Cavity: A Case Series.

DOI: 10.1016/j.jmig.2017.07.012

Year: 2018

Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis

DOI: 10.1093/humrep/dex321

Year: 2017

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2 The predicted hyper responder

DOI: 10.1093/humrep/dex319

Year: 2017

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1 The predicted poor responder

DOI: 10.1093/humrep/dex318

Year: 2017

Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial

DOI: 10.1016/S0140-6736(16)00231-2

Year: 2016

How to Prepare for a Conference?

How to Make the Decision?

When is the Procedure Performed?

What is Inadequate Support in Gynecology?

What Are Gonadotropins?

How Much Insoluble Fiber Should One Consume?

What is Non-Classical Congenital Adrenal Hyperplasia (NCAH)?

Why Are Leg Exercises Important for Women?

Why Might a Woman Need a Breast Pump?

What is Protection in Gynecology?

Partnered Content Networks

Relevant Topics